Abstract:Breast cancer is the most common type of malignancy among females. Previous studies examining breast cancer tissue have demonstrated the presence of stem cells, and have detected octamer‑binding protein 4 (Oct4) and Nanog transcription factor expression. In the present study, breast cancer stem cells (CSCs) were isolated and enriched from MDA‑MB‑231 breast cancer cell lines, and were defined as MDA‑MB‑231 stem cells using flow cytometry. The expression of Oct4 and Nanog in breast CSCs were detected by quantitative polymerase chain reaction and western blotting. RNA interference (RNAi) was used in order to downregulate the expression of Oct4 and Nanog. Drug resistance and tumor‑initiating capability following in vivo injection of MDA‑MB‑231 stem cells trans-duced with negative RNAi, Oct4 RNAi and Nanog RNAi were compared with that of MDA‑MB‑231 stem cells without siRNA transfection as a control group. In addition the capability of MDA‑MB‑231 breast cancer cells to initiate tumor formation in mice was compared with that of MDA‑MB‑231 stem cells. A paclitaxel inhibition test was also conducted in order to detect resistance of MDA‑MB‑231 breast cancer stem cells to this treatment. The MDA‑MB‑231 stem cells were revealed to exhibit elevated percentages of the cluster of differentiation (CD)44+CD24‑/low subset, high tumorigenicity and resistance to chemotherapy, all of which are characteristic stem cell properties. In addition, the MDA‑MB‑231 stem cells were more tumorigenic in vivo. Furthermore, the breast CSCs also expressed high levels of the Oct4 and Nanog transcription factors. Therefore, downregulation of Oct4 or Nanog expression may reduce chemotherapeutic drug resistance and tumorigenicity in breast CSCs. In conclusion, Oct4 and Nanog expression may be a key factor in the development of resistance to chemotherapy and tumor growth of breast CSCs. This finding indicates that Oct4 or Nanog‑targeted therapy may be a promising means of overcoming resistance to chemotherapy and inhibiting tumor growth in breast cancer treatment.

Inhibition of CD147 expression by RNA interference reduces proliferation, invasion and increases chemosensitivity in cancer stem cell-like HT-29 cells

Downregulation of CD 147 Expression by RNA Interference Inhibits HT 29 Cell Proliferation , Invasion and Tumorigenicity in Vitro and in Vivo

RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro

ResearchRNAi-mediated silencing of CD 147 inhibits tumor cell proliferation , invasion and increases chemosensitivity to cisplatin in SGC 7901 cells in vitro

CD147 silencing via RNA interference reduces tumor cell invasion, metastasis and increases chemosensitivity in pancreatic cancer cells.

Expression of CD147 in Advanced Non-Small Cell Lung Cancer Correlated with Cisplatin-Based Chemotherapy Resistance.

RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion.

Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference.

Therapeutic Anti-Cd147 Antibody Sensitizes Cells to Chemoradiotherapy Via Targeting Pancreatic Cancer Stem Cells.

RNAi-mediated silencing of CD147 increases the anticancer effects of cisplatin on cell proliferation, death and invasion in human hepatoma cellsin vitro

MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.

RNA interference targeting extracellular matrix metalloproteinase inducer (CD147) inhibits growth and increases chemosensitivity in human cervical cancer cells.

Inhibition Of Cd147 Gene Expression Via Rna Interference Reduces Tumor Cell Invasion, Tumorigenicity And Increases Chemosensitivity To Cisplatin In Laryngeal Carcinoma Hep2 Cells

CD147 Regulates Vascular Endothelial Growth Factor-a Expression, Tumorigenicity, and Chemosensitivity to Curcumin in Hepatocellular Carcinoma.

Inhibition of the Expression of CD147 by MicroRNA and Influence on the Biological Activities of Tumor in SiHa

[Rnai-Mediated Silencing of CD147 Inhibits the Proliferation and Infiltrations of Leukemic Cells SHI-1].

Mechanisms of inhibiting the proliferation of triple negative breast cancer cell lines by silencing the CD147 gene

Cd133 Silencing Inhibits Sternness Properties And Enhances Chemoradiosensitivity In Cd133-Positive Liver Cancer Stern Cells

Mir-449B Inhibits the Proliferation of SW1116 Colon Cancer Stem Cells Through Downregulation of CCND1 and E2F3 Expression

Reduced Tumorigenicity and Drug Resistance Through the Downregulation of Octamer-Binding Protein 4 and Nanog Transcriptional Factor Expression in Human Breast Stem Cells

Reduced CD146 Expression Promotes Tumorigenesis and Cancer Stemness in Colorectal Cancer Through Activating Wnt/β-catenin Signaling.